Building life science leadership
The IGES Institute has acquired majority shares in Southampton Science Park company Device Access.
Founded in 2010, Device Access works collaboratively with various NHS and UK Government bodies including the National Institute for Health and Care Excellence (NICE), The National Institute for Health Research (NIHR), and The UK Department of International Trade (DIT) in bringing new and innovative medical technologies to benefit patients faster. The company has a large client base of US, European and British medical device developers and a successful track record of navigating and supporting its clients into the NHS. It recently announced that it had successfully helped clients though 30 NICE Medical Technology appraisals.
Michael Branagan-Harris, Founder and CEO, will continue in his role and will additionally lead IGES’s UK business activities as Country Manager, working to bring the two markets closer together. He commented: “Device Access and the IGES Group unite extensive knowledge of approval, market launch and reimbursement of medical devices, and their cultures fit outstandingly. The deal strengthens our respective market positions and builds the potential for our growth in the European markets.”
With this majority acquisition, the IGES Group continues its European expansion, servicing the growing global medical devices market in which Germany and the UK constitute core markets.
IGES Director, Professor Bertram Häussler, said: “The UK is an important country for the development and application of medical devices. Furthermore, it has traditionally been seen as a European beach head for global companies to launch into Europe. The aim of this acquisition is to strengthen these connections and make them usable for all our international clients.”